The HABP4 was identified by cross-reactivity with Ki-1 (which recognizes CD30, =TNFRSF8), the first monoclonal antibody to identify neoplastic Hodgkin and Stenberg-Reed cells in Hodgkin’s lymphoma [6, 7]. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.